APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injection Cefuroxime Sodium

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Injection Cefuroxime Sodium Market Analysis and Forecast 2026-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchInjection Cefuroxime Sodium Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Injection Cefuroxime Sodium Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Injection Cefuroxime Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injection Cefuroxime Sodium Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Injection Cefuroxime Sodium Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Injection Cefuroxime Sodium market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Injection Cefuroxime Sodium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Injection Cefuroxime Sodium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Injection Cefuroxime Sodium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Injection Cefuroxime Sodium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Injection Cefuroxime Sodium include Teva Pharmaceutical Industries, Merck Europe B.V., Mylan Pharmaceuticals, Santen Pharmaceutical Co.,Ltd., Teva Takeda Yakuhin Ltd., Sumitomo Pharma America, Inc., SHIN POONG Pharmaceutical Co.,Ltd., Organon LLC and NAPP PHARMACEUTICALS LIMITED, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Injection Cefuroxime Sodium, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Injection Cefuroxime Sodium, also provides the revenue of main regions and countries. Of the upcoming market potential for Injection Cefuroxime Sodium, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Injection Cefuroxime Sodium revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Injection Cefuroxime Sodium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Injection Cefuroxime Sodium revenue, projected growth trends, production technology, application and end-user industry.

Injection Cefuroxime Sodium Segment by Company

Teva Pharmaceutical Industries

Merck Europe B.V.

Mylan Pharmaceuticals

Santen Pharmaceutical Co.,Ltd.

Teva Takeda Yakuhin Ltd.

Sumitomo Pharma America, Inc.

SHIN POONG Pharmaceutical Co.,Ltd.

Organon LLC

NAPP PHARMACEUTICALS LIMITED

LTL Pharma Co., Ltd.

Injection Cefuroxime Sodium Segment by Type

0.5g

1.0g

Injection Cefuroxime Sodium Segment by Application

Hospital

Clinic

Others

Injection Cefuroxime Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injection Cefuroxime Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injection Cefuroxime Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injection Cefuroxime Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Injection Cefuroxime Sodium in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Injection Cefuroxime Sodium company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injection Cefuroxime Sodium revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Injection Cefuroxime Sodium Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.5g Major Player Table 3. 1.0g Major Player Table 4. Global Injection Cefuroxime Sodium Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Others Major Player Table 8. Injection Cefuroxime Sodium Industry Trends Table 9. Injection Cefuroxime Sodium Industry Drivers Table 10. Injection Cefuroxime Sodium Industry Opportunities and Challenges Table 11. Injection Cefuroxime Sodium Industry Restraints Table 12. Global Injection Cefuroxime Sodium Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Injection Cefuroxime Sodium Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Injection Cefuroxime Sodium Market Share by Region (2021-2026) Table 15. Global Injection Cefuroxime Sodium Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Injection Cefuroxime Sodium Market Share by Region (2027-2032) Table 17. Global Injection Cefuroxime Sodium Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Injection Cefuroxime Sodium Revenue Market Share by Players (2021-2026) Table 19. Global Injection Cefuroxime Sodium Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Injection Cefuroxime Sodium Key Players Headquarters & Area Served Table 21. Global Injection Cefuroxime Sodium Players, Product Type & Application Table 22. Global Injection Cefuroxime Sodium Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Injection Cefuroxime Sodium by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Injection Cefuroxime Sodium Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Injection Cefuroxime Sodium Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Injection Cefuroxime Sodium Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Injection Cefuroxime Sodium Revenue Market Share by Type (2021-2026) Table 29. Global Injection Cefuroxime Sodium Revenue Market Share by Type (2027-2032) Table 30. Global Injection Cefuroxime Sodium Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Injection Cefuroxime Sodium Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Injection Cefuroxime Sodium Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Injection Cefuroxime Sodium Revenue Market Share by Application (2021-2026) Table 34. Global Injection Cefuroxime Sodium Revenue Market Share by Application (2027-2032) Table 35. Teva Pharmaceutical Industries Company Information Table 36. Teva Pharmaceutical Industries Business Overview Table 37. Teva Pharmaceutical Industries Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Teva Pharmaceutical Industries Injection Cefuroxime Sodium Product Portfolio Table 39. Teva Pharmaceutical Industries Recent Development Table 40. Merck Europe B.V. Company Information Table 41. Merck Europe B.V. Business Overview Table 42. Merck Europe B.V. Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck Europe B.V. Injection Cefuroxime Sodium Product Portfolio Table 44. Merck Europe B.V. Recent Development Table 45. Mylan Pharmaceuticals Company Information Table 46. Mylan Pharmaceuticals Business Overview Table 47. Mylan Pharmaceuticals Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Mylan Pharmaceuticals Injection Cefuroxime Sodium Product Portfolio Table 49. Mylan Pharmaceuticals Recent Development Table 50. Santen Pharmaceutical Co.,Ltd. Company Information Table 51. Santen Pharmaceutical Co.,Ltd. Business Overview Table 52. Santen Pharmaceutical Co.,Ltd. Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Santen Pharmaceutical Co.,Ltd. Injection Cefuroxime Sodium Product Portfolio Table 54. Santen Pharmaceutical Co.,Ltd. Recent Development Table 55. Teva Takeda Yakuhin Ltd. Company Information Table 56. Teva Takeda Yakuhin Ltd. Business Overview Table 57. Teva Takeda Yakuhin Ltd. Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Teva Takeda Yakuhin Ltd. Injection Cefuroxime Sodium Product Portfolio Table 59. Teva Takeda Yakuhin Ltd. Recent Development Table 60. Sumitomo Pharma America, Inc. Company Information Table 61. Sumitomo Pharma America, Inc. Business Overview Table 62. Sumitomo Pharma America, Inc. Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sumitomo Pharma America, Inc. Injection Cefuroxime Sodium Product Portfolio Table 64. Sumitomo Pharma America, Inc. Recent Development Table 65. SHIN POONG Pharmaceutical Co.,Ltd. Company Information Table 66. SHIN POONG Pharmaceutical Co.,Ltd. Business Overview Table 67. SHIN POONG Pharmaceutical Co.,Ltd. Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. SHIN POONG Pharmaceutical Co.,Ltd. Injection Cefuroxime Sodium Product Portfolio Table 69. SHIN POONG Pharmaceutical Co.,Ltd. Recent Development Table 70. Organon LLC Company Information Table 71. Organon LLC Business Overview Table 72. Organon LLC Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Organon LLC Injection Cefuroxime Sodium Product Portfolio Table 74. Organon LLC Recent Development Table 75. NAPP PHARMACEUTICALS LIMITED Company Information Table 76. NAPP PHARMACEUTICALS LIMITED Business Overview Table 77. NAPP PHARMACEUTICALS LIMITED Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. NAPP PHARMACEUTICALS LIMITED Injection Cefuroxime Sodium Product Portfolio Table 79. NAPP PHARMACEUTICALS LIMITED Recent Development Table 80. LTL Pharma Co., Ltd. Company Information Table 81. LTL Pharma Co., Ltd. Business Overview Table 82. LTL Pharma Co., Ltd. Injection Cefuroxime Sodium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. LTL Pharma Co., Ltd. Injection Cefuroxime Sodium Product Portfolio Table 84. LTL Pharma Co., Ltd. Recent Development Table 85. North America Injection Cefuroxime Sodium Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Injection Cefuroxime Sodium Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Injection Cefuroxime Sodium Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Injection Cefuroxime Sodium Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Injection Cefuroxime Sodium Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Injection Cefuroxime Sodium Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Injection Cefuroxime Sodium Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Injection Cefuroxime Sodium Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Injection Cefuroxime Sodium Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Injection Cefuroxime Sodium Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Injection Cefuroxime Sodium Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Injection Cefuroxime Sodium Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Injection Cefuroxime Sodium Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Injection Cefuroxime Sodium Revenue by Country (US$ Million) & (2027-2032) Table 99. China Injection Cefuroxime Sodium Revenue by Type (2021-2026) & (US$ Million) Table 100. China Injection Cefuroxime Sodium Revenue by Type (2027-2032) & (US$ Million) Table 101. China Injection Cefuroxime Sodium Revenue by Application (2021-2026) & (US$ Million) Table 102. China Injection Cefuroxime Sodium Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Injection Cefuroxime Sodium Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Injection Cefuroxime Sodium Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Injection Cefuroxime Sodium Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Injection Cefuroxime Sodium Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Injection Cefuroxime Sodium Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Injection Cefuroxime Sodium Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Injection Cefuroxime Sodium Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Injection Cefuroxime Sodium Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Injection Cefuroxime Sodium Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Injection Cefuroxime Sodium Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Injection Cefuroxime Sodium Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Injection Cefuroxime Sodium Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Injection Cefuroxime Sodium Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Injection Cefuroxime Sodium Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Injection Cefuroxime Sodium Image Figure 2. Global Injection Cefuroxime Sodium Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injection Cefuroxime Sodium Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.5g Image Figure 5. 1.0g Image Figure 6. Global Injection Cefuroxime Sodium Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Injection Cefuroxime Sodium Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Injection Cefuroxime Sodium Market Size (US$ Million) & (2021-2032) Figure 12. Global Injection Cefuroxime Sodium Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Injection Cefuroxime Sodium Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Injection Cefuroxime Sodium Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Injection Cefuroxime Sodium Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Injection Cefuroxime Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Injection Cefuroxime Sodium Revenue Market Share by Type (2021-2032) Figure 19. Global Injection Cefuroxime Sodium Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Injection Cefuroxime Sodium Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Injection Cefuroxime Sodium Revenue Market Share by Application (2021-2032) Figure 22. North America Injection Cefuroxime Sodium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Injection Cefuroxime Sodium Revenue Share by Type (2021-2032) Figure 24. North America Injection Cefuroxime Sodium Revenue Share by Application (2021-2032) Figure 25. North America Injection Cefuroxime Sodium Revenue Share by Country (2021-2032) Figure 26. United States Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Injection Cefuroxime Sodium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Injection Cefuroxime Sodium Revenue Share by Type (2021-2032) Figure 31. Europe Injection Cefuroxime Sodium Revenue Share by Application (2021-2032) Figure 32. Europe Injection Cefuroxime Sodium Revenue Share by Country (2021-2032) Figure 33. Germany Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Injection Cefuroxime Sodium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Injection Cefuroxime Sodium Revenue Share by Type (2021-2032) Figure 43. China Injection Cefuroxime Sodium Revenue Share by Application (2021-2032) Figure 44. Asia Injection Cefuroxime Sodium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Injection Cefuroxime Sodium Revenue Share by Type (2021-2032) Figure 46. Asia Injection Cefuroxime Sodium Revenue Share by Application (2021-2032) Figure 47. Asia Injection Cefuroxime Sodium Revenue Share by Region (2021-2032) Figure 48. Japan Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Injection Cefuroxime Sodium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Injection Cefuroxime Sodium Revenue Share by Type (2021-2032) Figure 56. SAMEA Injection Cefuroxime Sodium Revenue Share by Application (2021-2032) Figure 57. SAMEA Injection Cefuroxime Sodium Revenue Share by Country (2021-2032) Figure 58. Brazil Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Injection Cefuroxime Sodium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5g
  • 1.0g
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Merck Europe B.V.
  • Mylan Pharmaceuticals
  • Santen Pharmaceutical Co.,Ltd.
  • Teva Takeda Yakuhin Ltd.
  • Sumitomo Pharma America, Inc.
  • SHIN POONG Pharmaceutical Co.,Ltd.
  • Organon LLC
  • NAPP PHARMACEUTICALS LIMITED
  • LTL Pharma Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Injection Cefuroxime Sodium Market by Type
  3. 1.2.1 Global Injection Cefuroxime Sodium Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.5g
  5. 1.2.3 1.0g
  6. 1.3 Injection Cefuroxime Sodium Market by Application
  7. 1.3.1 Global Injection Cefuroxime Sodium Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Injection Cefuroxime Sodium Market Dynamics
  1. 2.1 Injection Cefuroxime Sodium Industry Trends
  2. 2.2 Injection Cefuroxime Sodium Industry Drivers
  3. 2.3 Injection Cefuroxime Sodium Industry Opportunities and Challenges
  4. 2.4 Injection Cefuroxime Sodium Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Injection Cefuroxime Sodium Market Perspective (2021-2032)
  2. 3.2 Global Injection Cefuroxime Sodium Growth Trends by Region
  3. 3.2.1 Global Injection Cefuroxime Sodium Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Injection Cefuroxime Sodium Market Size by Region (2021-2026)
  5. 3.2.3 Global Injection Cefuroxime Sodium Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Injection Cefuroxime Sodium Revenue by Players
  2. 4.1.1 Global Injection Cefuroxime Sodium Revenue by Players (2021-2026)
  3. 4.1.2 Global Injection Cefuroxime Sodium Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Injection Cefuroxime Sodium Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Injection Cefuroxime Sodium Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Injection Cefuroxime Sodium Key Players Headquarters & Area Served
  7. 4.4 Global Injection Cefuroxime Sodium Players, Product Type & Application
  8. 4.5 Global Injection Cefuroxime Sodium Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Injection Cefuroxime Sodium Market CR5 and HHI
  11. 4.6.3 2025 Injection Cefuroxime Sodium Tier 1, Tier 2, and Tier 3
5 Injection Cefuroxime Sodium Market Size by Type
  1. 5.1 Global Injection Cefuroxime Sodium Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Injection Cefuroxime Sodium Revenue by Type (2021-2032)
  3. 5.3 Global Injection Cefuroxime Sodium Revenue Market Share by Type (2021-2032)
6 Injection Cefuroxime Sodium Market Size by Application
  1. 6.1 Global Injection Cefuroxime Sodium Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Injection Cefuroxime Sodium Revenue by Application (2021-2032)
  3. 6.3 Global Injection Cefuroxime Sodium Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries
  2. 7.1.1 Teva Pharmaceutical Industries Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Injection Cefuroxime Sodium Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 7.2 Merck Europe B.V.
  8. 7.2.1 Merck Europe B.V. Company Information
  9. 7.2.2 Merck Europe B.V. Business Overview
  10. 7.2.3 Merck Europe B.V. Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck Europe B.V. Injection Cefuroxime Sodium Product Portfolio
  12. 7.2.5 Merck Europe B.V. Recent Developments
  13. 7.3 Mylan Pharmaceuticals
  14. 7.3.1 Mylan Pharmaceuticals Company Information
  15. 7.3.2 Mylan Pharmaceuticals Business Overview
  16. 7.3.3 Mylan Pharmaceuticals Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Pharmaceuticals Injection Cefuroxime Sodium Product Portfolio
  18. 7.3.5 Mylan Pharmaceuticals Recent Developments
  19. 7.4 Santen Pharmaceutical Co.,Ltd.
  20. 7.4.1 Santen Pharmaceutical Co.,Ltd. Company Information
  21. 7.4.2 Santen Pharmaceutical Co.,Ltd. Business Overview
  22. 7.4.3 Santen Pharmaceutical Co.,Ltd. Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Santen Pharmaceutical Co.,Ltd. Injection Cefuroxime Sodium Product Portfolio
  24. 7.4.5 Santen Pharmaceutical Co.,Ltd. Recent Developments
  25. 7.5 Teva Takeda Yakuhin Ltd.
  26. 7.5.1 Teva Takeda Yakuhin Ltd. Company Information
  27. 7.5.2 Teva Takeda Yakuhin Ltd. Business Overview
  28. 7.5.3 Teva Takeda Yakuhin Ltd. Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Teva Takeda Yakuhin Ltd. Injection Cefuroxime Sodium Product Portfolio
  30. 7.5.5 Teva Takeda Yakuhin Ltd. Recent Developments
  31. 7.6 Sumitomo Pharma America, Inc.
  32. 7.6.1 Sumitomo Pharma America, Inc. Company Information
  33. 7.6.2 Sumitomo Pharma America, Inc. Business Overview
  34. 7.6.3 Sumitomo Pharma America, Inc. Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sumitomo Pharma America, Inc. Injection Cefuroxime Sodium Product Portfolio
  36. 7.6.5 Sumitomo Pharma America, Inc. Recent Developments
  37. 7.7 SHIN POONG Pharmaceutical Co.,Ltd.
  38. 7.7.1 SHIN POONG Pharmaceutical Co.,Ltd. Company Information
  39. 7.7.2 SHIN POONG Pharmaceutical Co.,Ltd. Business Overview
  40. 7.7.3 SHIN POONG Pharmaceutical Co.,Ltd. Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  41. 7.7.4 SHIN POONG Pharmaceutical Co.,Ltd. Injection Cefuroxime Sodium Product Portfolio
  42. 7.7.5 SHIN POONG Pharmaceutical Co.,Ltd. Recent Developments
  43. 7.8 Organon LLC
  44. 7.8.1 Organon LLC Company Information
  45. 7.8.2 Organon LLC Business Overview
  46. 7.8.3 Organon LLC Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Organon LLC Injection Cefuroxime Sodium Product Portfolio
  48. 7.8.5 Organon LLC Recent Developments
  49. 7.9 NAPP PHARMACEUTICALS LIMITED
  50. 7.9.1 NAPP PHARMACEUTICALS LIMITED Company Information
  51. 7.9.2 NAPP PHARMACEUTICALS LIMITED Business Overview
  52. 7.9.3 NAPP PHARMACEUTICALS LIMITED Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  53. 7.9.4 NAPP PHARMACEUTICALS LIMITED Injection Cefuroxime Sodium Product Portfolio
  54. 7.9.5 NAPP PHARMACEUTICALS LIMITED Recent Developments
  55. 7.10 LTL Pharma Co., Ltd.
  56. 7.10.1 LTL Pharma Co., Ltd. Company Information
  57. 7.10.2 LTL Pharma Co., Ltd. Business Overview
  58. 7.10.3 LTL Pharma Co., Ltd. Injection Cefuroxime Sodium Revenue and Gross Margin (2021-2026)
  59. 7.10.4 LTL Pharma Co., Ltd. Injection Cefuroxime Sodium Product Portfolio
  60. 7.10.5 LTL Pharma Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Injection Cefuroxime Sodium Revenue (2021-2032)
  2. 8.2 North America Injection Cefuroxime Sodium Revenue by Type (2021-2032)
  3. 8.2.1 North America Injection Cefuroxime Sodium Revenue by Type (2021-2026)
  4. 8.2.2 North America Injection Cefuroxime Sodium Revenue by Type (2027-2032)
  5. 8.3 North America Injection Cefuroxime Sodium Revenue Share by Type (2021-2032)
  6. 8.4 North America Injection Cefuroxime Sodium Revenue by Application (2021-2032)
  7. 8.4.1 North America Injection Cefuroxime Sodium Revenue by Application (2021-2026)
  8. 8.4.2 North America Injection Cefuroxime Sodium Revenue by Application (2027-2032)
  9. 8.5 North America Injection Cefuroxime Sodium Revenue Share by Application (2021-2032)
  10. 8.6 North America Injection Cefuroxime Sodium Revenue by Country
  11. 8.6.1 North America Injection Cefuroxime Sodium Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Injection Cefuroxime Sodium Revenue by Country (2021-2026)
  13. 8.6.3 North America Injection Cefuroxime Sodium Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Injection Cefuroxime Sodium Revenue (2021-2032)
  2. 9.2 Europe Injection Cefuroxime Sodium Revenue by Type (2021-2032)
  3. 9.2.1 Europe Injection Cefuroxime Sodium Revenue by Type (2021-2026)
  4. 9.2.2 Europe Injection Cefuroxime Sodium Revenue by Type (2027-2032)
  5. 9.3 Europe Injection Cefuroxime Sodium Revenue Share by Type (2021-2032)
  6. 9.4 Europe Injection Cefuroxime Sodium Revenue by Application (2021-2032)
  7. 9.4.1 Europe Injection Cefuroxime Sodium Revenue by Application (2021-2026)
  8. 9.4.2 Europe Injection Cefuroxime Sodium Revenue by Application (2027-2032)
  9. 9.5 Europe Injection Cefuroxime Sodium Revenue Share by Application (2021-2032)
  10. 9.6 Europe Injection Cefuroxime Sodium Revenue by Country
  11. 9.6.1 Europe Injection Cefuroxime Sodium Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Injection Cefuroxime Sodium Revenue by Country (2021-2026)
  13. 9.6.3 Europe Injection Cefuroxime Sodium Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Injection Cefuroxime Sodium Revenue (2021-2032)
  2. 10.2 China Injection Cefuroxime Sodium Revenue by Type (2021-2032)
  3. 10.2.1 China Injection Cefuroxime Sodium Revenue by Type (2021-2026)
  4. 10.2.2 China Injection Cefuroxime Sodium Revenue by Type (2027-2032)
  5. 10.3 China Injection Cefuroxime Sodium Revenue Share by Type (2021-2032)
  6. 10.4 China Injection Cefuroxime Sodium Revenue by Application (2021-2032)
  7. 10.4.1 China Injection Cefuroxime Sodium Revenue by Application (2021-2026)
  8. 10.4.2 China Injection Cefuroxime Sodium Revenue by Application (2027-2032)
  9. 10.5 China Injection Cefuroxime Sodium Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Injection Cefuroxime Sodium Revenue (2021-2032)
  2. 11.2 Asia Injection Cefuroxime Sodium Revenue by Type (2021-2032)
  3. 11.2.1 Asia Injection Cefuroxime Sodium Revenue by Type (2021-2026)
  4. 11.2.2 Asia Injection Cefuroxime Sodium Revenue by Type (2027-2032)
  5. 11.3 Asia Injection Cefuroxime Sodium Revenue Share by Type (2021-2032)
  6. 11.4 Asia Injection Cefuroxime Sodium Revenue by Application (2021-2032)
  7. 11.4.1 Asia Injection Cefuroxime Sodium Revenue by Application (2021-2026)
  8. 11.4.2 Asia Injection Cefuroxime Sodium Revenue by Application (2027-2032)
  9. 11.5 Asia Injection Cefuroxime Sodium Revenue Share by Application (2021-2032)
  10. 11.6 Asia Injection Cefuroxime Sodium Revenue by Country
  11. 11.6.1 Asia Injection Cefuroxime Sodium Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Injection Cefuroxime Sodium Revenue by Country (2021-2026)
  13. 11.6.3 Asia Injection Cefuroxime Sodium Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Injection Cefuroxime Sodium Revenue (2021-2032)
  2. 12.2 SAMEA Injection Cefuroxime Sodium Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Injection Cefuroxime Sodium Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Injection Cefuroxime Sodium Revenue by Type (2027-2032)
  5. 12.3 SAMEA Injection Cefuroxime Sodium Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Injection Cefuroxime Sodium Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Injection Cefuroxime Sodium Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Injection Cefuroxime Sodium Revenue by Application (2027-2032)
  9. 12.5 SAMEA Injection Cefuroxime Sodium Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Injection Cefuroxime Sodium Revenue by Country
  11. 12.6.1 SAMEA Injection Cefuroxime Sodium Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Injection Cefuroxime Sodium Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Injection Cefuroxime Sodium Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst